# Bipolar Disorder Study for Men and Women

> **NCT00056277** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 150 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** lamotrigine

## Key facts

- **NCT ID:** NCT00056277
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-02-27
- **Primary completion:** 2005-08-01
- **Final completion:** 2005-12-14
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2017-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056277, "Bipolar Disorder Study for Men and Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00056277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*